How are patient organizations taking on the challenge of diversity, equity, and inclusion within biomedical research to create better health outcomes for all patient populations, especially those historically excluded from research and...

Rajiv Ahuja, associate director at the Milken Institute, focusing on the future of aging, moderates this Advances in Science webinar with featured guest Richard J. Hodes, M.D., Director of the National Institute on Aging (NIA) at the...

How are nonprofit organizations leveraging venture philanthropy to accelerate the development of treatments and cures? As part of The Research Acceleration and Innovation Network (TRAIN) webinar series, FasterCures takes a deeper dive into...

Data from and about patients is essential in order to advance biomedical research, but its collection and dissemination can be a significant investment of time and resources for patient organizations that choose to be the intermediary...

Despite significant advances in renewable energy, biotech, and life sciences jobs, the journey from generating breakthrough discoveries to creating accessible jobs across green and blue industries remains difficult to quantify. Industries...

How can nonprofit organizations develop and implement a venture philanthropy investment strategy? As part of The Research Acceleration and Innovation Network (TRAIN) webinar series, FasterCures collaborated with MI Philanthropy to take a...

One thing has been made abundantly clear during the COVID-19 pandemic. Californians are quitting their jobs at unprecedented rates. The recent job reports only continue to solidify this notion. Whether searching for better pay, more...

While employment in much of the United States has recovered successfully from the fallout of the COVID-19 pandemic, California remains one of the few states that has struggled to recoup jobs at a pace on par with the rest of the nation...

In a webinar on September 23, 2020, FasterCures brought together Peter Marks, director of the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research, Gwen Nichols, chief medical officer of the Leukemia &...